It has been confirmed that CHAF1B is overexpressed in laryngeal cancer, squamous cell carcinoma [26] ,high-grade gliomas,prostatic cancer and lung cancer, and its high expression leads to a shorter survival period for high-grade gliomas [27] ,prostatic cancer [28] and patients lung cancer. Here, CHAF1B is linked to central nervous system cancer.